热点资讯
OD体育
关于OD
OD资讯
OD盘口
2026世界杯
ODapp下载

推官网，引流量

直推官网引流，大量子站导流 效果持久显著

批量建站，提收录

形成站群推广模式 让搜索引擎大量收录！

提权重，树权威

实现权重提升 树立行业权威

部署快，自主可控

免费下载

省成本，提效率

多分站齐推广，性价比高 批量数据分析，帮助及时调整优化

OD体育

2026-05-17OD体育app官网 618“值得捡漏”的旗舰手机, 2K屏+...
2026-05-17OD体育 小米5月新品定了, 纯白陶瓷有点好意思瞻念...
2026-05-16OD体育app [企业风姿]七天教唆机器东谈主“干活”! 海...
2026-05-16OD体育app官网 “海淘”智能穿着修复或被植入窃密安装, ...
2026-05-16OD体育 儋州电板托运一般要若干钱...
2026-05-16OD体育app 随州寄电板用什么物流...
关于OD
OD体育app官网 特朗普访华, 施展欧盟愚蠢到家!
关于OD
OD体育app官网 特朗普访华, 施展欧
特朗普访华，施展欧盟很愚蠢！ 特朗普访华很得胜，但目下欧盟又尬在那了，因为他们还
查看更多
OD体育app官网 朱民重磅发声: 好意思元信用束缚诬捏, “寰宇需要新的均衡的货币体系”
关于OD
OD体育app官网 朱民重磅发声: 好意
中新经纬5月18日电(董湘依)跟着好意思元体系里面实体经济的失衡，东说念主民币外
查看更多
OD体育app 蒙哥马利: 保捏得胜的威望很环节, 咱们遭遇好多不毛但齐挺过来了
关于OD
OD体育app 蒙哥马利: 保捏得胜的威
开元棋牌官方网站入口 直播吧5月15日讯中超第12轮，北京国安主场4-2驯顺青岛
查看更多
OD体育app官网 恭喜！他们官宣结婚
日前，国乒队员牛冠凯在酬酢平台告示喜信，晒出共创视频，与竹马之交的退役畅通员段冬
OD体育 荣耀WIN2曝光: 骁龙8E6Pro+万级电板+散热电扇, 正面交锋K100系列
全球知谈，手机圈这两年的竞争还是到了尖锐化的进度，各家子品牌和性能线齐在拚命堆电
OD体育app官网 中国江山这样好意思, 为啥还有东说念主偏疼放洋旅行? 网友的共享原因太推行
凡是稍稍可爱外出游玩的东说念主，齐不得不感喟我们国度的气候有多耐看。从东北漫天飞

OD资讯

ODZIXUN

OD资讯

查看更多

  • OD体育

    OD体育

  • 关于OD

    关于OD

  • OD资讯

    OD资讯

  • OD盘口

    OD盘口

OD盘口

  • OD盘口

OD体育(ODSports)官网入口

OD体育app官网 柬埔寨贴纸签办理全攻略，这几个坑别踩
OD体育
关于OD
OD资讯
  • icon

    OD体育

    OD体育

  • icon

    关于OD

    关于OD

  • icon

    OD资讯

    OD资讯

  • icon

    OD盘口

    OD盘口

临床医学名词词典
首页 > 按专业查询名词 > 查询PubMed相关文献
返回上一级
名词信息
加入我的词汇本
Pubmed相关的文献
Abbott,FischerandLucas's fusion method相关文献:
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.
Nicholls SJ, Bhatt DL, Buse JB, Prato SD, Kahn SE, Lincoff AM, McGuire DK, Nauck MA, Nissen SE, Sattar N, Zinman B, Zoungas S, Basile J, Bartee A, Miller D, Nishiyama H, Pavo I, Weerakkody G, Wiese RJ, D'Alessio D; SURPASS-CVOT investigators.
Am Heart J. 2024 Jan;267:1-11. doi: 10.1016/j.ahj.2023.09.007. Epub 2023 Sep 25.
PMID:37758044
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.
Ison MG, Papi A, Athan E, Feldman RG, Langley JM, Lee DG, Leroux-Roels I, Martinon-Torres F, Schwarz TF, van Zyl-Smit RN, Verheust C, Dezutter N, Gruselle O, Fissette L, David MP, Kostanyan L, Hulstrøm V, Olivier A, Van der Wielen M, Descamps D; AReSVi-006 Study Group.
Clin Infect Dis. 2024 Jun 14;78(6):1732-1744. doi: 10.1093/cid/ciae010.
PMID:38253338
State-of-the-Art Review: Diagnosis and Management of Spinal Implant Infections.
Tai DBG, Patel R, Lovecchio F, Kwee T, Wouthuyzen-Bakker M.
Clin Infect Dis. 2024 Dec 17;79(6):e65-e71. doi: 10.1093/cid/ciae436.
PMID:39688553
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.
Badve SV, Bilal A, Lee MMY, Sattar N, Gerstein HC, Ruff CT, McMurray JJV, Rossing P, Bakris G, Mahaffey KW, Mann JFE, Colhoun HM, Tuttle KR, Pratley RE, Perkovic V.
Lancet Diabetes Endocrinol. 2025 Jan;13(1):15-28. doi: 10.1016/S2213-8587(24)00271-7. Epub 2024 Nov 25.
PMID:39608381
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.
Kosiborod MN, Deanfield J, Pratley R, Borlaug BA, Butler J, Davies MJ, Emerson SS, Kahn SE, Kitzman DW, Lingvay I, Mahaffey KW, Petrie MC, Plutzky J, Rasmussen S, Rönnbäck C, Shah SJ, Verma S, Weeke PE, Lincoff AM; SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM Trial Committees and Investigators.
Lancet. 2024 Sep 7;404(10456):949-961. doi: 10.1016/S0140-6736(24)01643-X. Epub 2024 Aug 30.
PMID:39222642
Successful Diagnosis of Sacroiliac Joint Dysfunction.
Buchanan P, Vodapally S, Lee DW, Hagedorn JM, Bovinet C, Strand N, Sayed D, Deer T.
J Pain Res. 2021 Oct 8;14:3135-3143. doi: 10.2147/JPR.S327351. eCollection 2021.
PMID:34675642
Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial.
Inagaki N, Takeuchi M, Oura T, Imaoka T, Seino Y.
Lancet Diabetes Endocrinol. 2022 Sep;10(9):623-633. doi: 10.1016/S2213-8587(22)00188-7. Epub 2022 Jul 30.
PMID:35914543
Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis.
Klein AL, Imazio M, Cremer P, Brucato A, Abbate A, Fang F, Insalaco A, LeWinter M, Lewis BS, Lin D, Luis SA, Nicholls SJ, Pano A, Wheeler A, Paolini JF; RHAPSODY Investigators.
N Engl J Med. 2021 Jan 7;384(1):31-41. doi: 10.1056/NEJMoa2027892. Epub 2020 Nov 16.
PMID:33200890
COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics.
Agarwal R, Green JB, Heerspink HJL, Mann JFE, McGill JB, Mottl AK, Rosenstock J, Rossing P, Vaduganathan M, Brinker M, Edfors R, Li N, Scheerer MF, Scott C, Nangaku M; CONFIDENCE investigators.
Nephrol Dial Transplant. 2025 Aug 1;40(8):1559-1569. doi: 10.1093/ndt/gfaf022.
PMID:39916475
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial.
Pratley RE, Tuttle KR, Rossing P, Rasmussen S, Perkovic V, Nielsen OW, Mann JFE, MacIsaac RJ, Kosiborod MN, Kamenov Z, Idorn T, Hansen MB, Hadjadj S, Bakris G, Baeres FMM, Mahaffey KW; FLOW Trial Committees and Investigators.
J Am Coll Cardiol. 2024 Oct 22;84(17):1615-1628. doi: 10.1016/j.jacc.2024.08.004. Epub 2024 Aug 30.
PMID:39217553
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3